← Edwards Lifesciences Corp
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and Cash Equivalents, at Carrying Value | $930.1m | $818.3m | $714.1m | $1.2b | $1.2b | $862.8m | $769.0m | $1.1b | $3.0b | $2.9b | |
| Short-term Investments | $341.0m | $519.2m | $242.4m | $337.8m | $219.4m | $604.0m | $446.3m | $500.5m | $930.7m | $1.3b | |
| Inventory, Net | $396.6m | $554.9m | $607.0m | $640.9m | $802.3m | $726.7m | $875.5m | $1.2b | $1.1b | $1.1b | |
| Assets, Current | $2.2b | $2.5b | $2.3b | $3.0b | $3.1b | $3.2b | $3.1b | $4.0b | $6.3b | $6.7b | |
| Property, Plant and Equipment, Net | $580.0m | $679.7m | $867.5m | $1.1b | $1.4b | $1.5b | $1.6b | $1.7b | $1.7b | $1.8b | |
| Goodwill | $626.1m | $1.1b | $1.1b | $1.2b | $1.2b | $1.2b | $1.2b | $1.3b | $1.8b | $1.8b | |
| Intangible Assets, Net (Excluding Goodwill) | $204.8m | $468.0m | $343.2m | $336.5m | $331.4m | $323.6m | $285.2m | $428.4m | $1.2b | $1.1b | |
| Operating Lease, Right-of-Use Asset | — | — | — | $80.1m | $94.2m | $92.1m | $92.3m | $94.0m | $98.2m | $102.7m | |
| Other Assets, Noncurrent | $123.2m | $108.9m | $33.6m | $101.8m | $119.6m | $110.8m | $299.1m | $463.7m | $721.6m | $730.2m | |
| Additional Financial Items | |||||||||||
| Accounts Receivable, after Allowance for Credit Loss, Current | $365.5m | $421.6m | $456.9m | $543.6m | $514.6m | $582.2m | $643.0m | $775.1m | $609.1m | $659.6m | |
| Assets | $4.5b | $5.7b | $5.3b | $6.5b | $7.2b | $8.5b | $8.3b | $9.4b | $13.1b | $13.7b | |
| LIABILITIES AND EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Operating Lease, Liability, Current | — | — | — | $25.5m | $27.2m | $25.5m | $25.5m | $24.9m | $23.4m | $24.5m | |
| Accounts Payable, Current | $97.1m | $116.6m | $134.0m | $180.4m | $196.5m | $204.5m | $201.9m | $201.4m | $197.4m | $227.5m | |
| Operating Lease, Liability, Noncurrent | — | — | — | $58.9m | $72.7m | $69.1m | $69.5m | $73.0m | $78.9m | $82.6m | |
| Long-term Debt, Current Maturities | — | $598.0m | $0 | — | — | — | — | — | — | — | |
| Long-term Debt, Excluding Current Maturities | $822.3m | $438.4m | $593.8m | $594.4m | $595.0m | $595.7m | $596.3m | $597.0m | $597.7m | $598.3m | |
| Liabilities, Current | $532.5m | $1.4b | $876.6m | $902.4m | $893.9m | $1.0b | $1.0b | $1.2b | $1.5b | $1.8b | |
| Other Liabilities, Noncurrent | $306.4m | $147.1m | $150.0m | $203.3m | $252.4m | $267.3m | $217.5m | $264.3m | $357.5m | $362.3m | |
| Liabilities | — | — | — | — | — | $2.7b | $2.5b | $2.6b | $3.0b | $3.4b | |
| Stockholders’ equity: | |||||||||||
| Preferred Stock, Value, Issued | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Common Stock, Value, Issued | $242.6m | $212.0m | $215.2m | $218.1m | $636.4m | $642.0m | $646.3m | $650.5m | $654.8m | $658.7m | |
| Retained Earnings (Accumulated Deficit) | $3.9b | $2.0b | $2.7b | $3.7b | $4.6b | $6.1b | $7.6b | $9.0b | $13.2b | $14.2b | |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | ($198.4m) | ($132.7m) | ($138.5m) | ($156.0m) | ($161.1m) | ($157.7m) | ($254.9m) | ($242.8m) | ($244.5m) | ($238.3m) | |
| Additional Paid in Capital, Common Stock | $1.2b | $1.2b | $1.4b | $1.6b | $1.4b | $1.7b | $2.0b | $2.3b | $2.6b | $2.8b | |
| Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax | — | — | — | — | — | — | — | — | $4.1m | ($800k) | |
| Stockholders' Equity Attributable to Parent | $2.6b | $3.0b | $3.1b | $4.1b | $4.6b | $5.8b | $5.8b | $6.7b | $10.0b | $10.3b | |
| Stockholders' Equity Attributable to Noncontrolling Interest | — | — | — | — | — | — | — | $69.4m | $64.5m | $0 | |
| Liabilities and Equity | $4.5b | $5.7b | $5.3b | $6.5b | $7.2b | $8.5b | $8.3b | $9.4b | $13.1b | $13.7b |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.